Cite
APA Citation
Giannatempo, P., Anichini, A., Raggi, D., Cordareschi, E., Nicolai, N., Colecchia, M., Salvioni, R., Valagussa, P., Gianni, A., & Necchi, A. (n.d.). 18TiPDESIGN OF A PHASE 2 STUDY OF BRENTUXIMAB VEDOTIN (SGN-35) AS SALVAGE THERAPY FOR MALES WITH CHEMORESISTANT GERM-CELL TUMORS (GCT). Annals of oncology, 25, vi6. http://access.bl.uk/ark:/81055/vdc_100097086354.0x00001e